Severity
Moderate
FDA Drug recall · Reported December 9, 2015
Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Geritrex Corp recalled Carbo-O-Philic 40 Gel 40% (Urea) NET WT tube, .5 oz (15 g), Rx Only For topical use only,… - a moderate-severity action.
Carbo-O-Philic 40 Gel 40% (Urea) NET WT tube, .5 oz (15 g), Rx Only For topical use only,… was recalled by Geritrex Corp in December 9, 2015. Reason: Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misb…. Check the official notice for the remedy. Verify recall #D-0391-2016 with the FDA Drug before acting.
The recall
Geritrex Corp issued this moderate-severity FDA Drug recall-Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misb….
Sourced from official FDA Drug enforcement records. Verify recall #D-0391-2016 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0391-2016) was formally reported on December 9, 2015, with the manufacturer initiating the action on October 27, 2015. It is classified under Moderate severity (Class II), with a current status of Terminated. Geritrex Corp is listed as the recalling firm, operating out of Mount Vernon, NY. Federal records list the affected scope as 1,032 tubes.
The documented reason for this recall is: Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded. Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
1,032 tubes
Related Recalls
6
5 from same agency
Carbo-O-Philic 40 Gel 40% (Urea) NET WT tube, .5 oz (15 g), Rx Only For topical use only, Distributed byGeritrex Corporation 144, Mount Vernon, NY 10550, NDC 54162-016-15
Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0391-2016 |
| Date reported | December 9, 2015 |
| Date initiated | October 27, 2015 |
| Recalling firm | Geritrex Corp |
| Firm location | Mount Vernon, NY |
| Affected scope | 1,032 tubes |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported December 9, 2015. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.